(Q42450636)

31 October 2017

Mutations in EGFR, BRAF and RAS are rare in triple-negative and basal-like breast cancers from Caucasian women (English)

1 reference

31 October 2017

9

1 reference

31 October 2017

Georgia Chenevix-Trench

11

object named as

G Chenevix Trench

1 reference

31 October 2017

10

S R Lakhani

1 reference

31 October 2017

E Tilch

1

1 reference

31 October 2017

T Seidens

2

1 reference

31 October 2017

S Cocciardi

3

1 reference

31 October 2017

L E Reid

4

1 reference

31 October 2017

D Byrne

5

1 reference

31 October 2017

P T Simpson

6

1 reference

31 October 2017

A C Vargas

7

1 reference

31 October 2017

M C Cummings

8

1 reference

31 October 2017

language of work or name

English

0 references

publication date

7 December 2013

1 reference

Breast Cancer Research and Treatment

31 October 2017

1 reference

31 October 2017

143

1 reference

31 October 2017

2

1 reference

31 October 2017

385-392

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-013-2798-1

31 October 2017

0 references

cites work

Clinical characteristics of different histologic types of breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Immunohistochemical markers as predictive tools for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Histological and molecular types of breast cancer: is there a unifying taxonomy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Gene expression profiling: changing face of breast cancer classification and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Basal-like breast carcinomas: clinical outcome and response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

How basal are triple-negative breast cancers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Intratumoral expression level of epidermal growth factor receptor and cytokeratin 5/6 is significantly associated with nodal and distant metastases in patients with basal-like triple-negative breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Phase II and tumor pharmacodynamic study of gefitinib in patients with advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Prognostic and predictive value of HER2 extracellular domain in metastatic breast cancer treated with lapatinib and paclitaxel in a randomized phase III study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Emerging targeted therapies in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Updates in the treatment of basal/triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Sequence analysis of mutations and translocations across breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

The genomic landscapes of human breast and colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Lack of EGFR-activating mutations in European patients with triple-negative breast cancer could emphasise geographic and ethnic variations in breast cancer mutation profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Protein expression, gene amplification, and mutational analysis of EGFR in triple-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

A transforming mutation in the pleckstrin homology domain of AKT1 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Diverse somatic mutation patterns and pathway alterations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

The Met oncogene and basal-like breast cancer: another culprit to watch out for?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Effect of epidermal growth factor receptor tyrosine kinase domain mutations on the outcome of patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

Relevance of PTEN loss in brain metastasis formation in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

High-throughput oncogene mutation profiling in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2798-1

10.1007/S10549-013-2798-1

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

31 October 2017

0 references

1 reference